Type 2 Diabetes Mellitus-related Changes in Left Ventricular Structure and Function in Patients with Chronic Kidney Disease

Overview

Journal Oncotarget

Specialty Oncology

Date 2018 Mar 28

PMID 29581872

Citations 4

Authors

Pei-Yu Wu

Jiun-Chi Huang

Szu-Chia Chen

Ling-I Chen

Affiliations

Soon will be listed here.

Abstract

Type 2 Diabetes mellitus (DM) is the leading cause of chronic kidney disease (CKD) worldwide, and is associated with an increased risk of left ventricular (LV) hypertrophy, LV systolic and diastolic dysfunctions. The aim of this study was to investigate abnormal echocardiographic findings in patients with CKD with and without DM, and identify the factors associated with these abnormalities. We enrolled 356 pre-dialysis patients with CKD (stages 3-5), including 208 with DM and 148 without DM. The structure and systolic and diastolic functions of the left ventricle were assessed using echocardiography, and the clinical and echocardiographic parameters were analyzed. The patients with DM had higher rates of observed/predicted left ventricular mass > 128% (69.5% vs. 56.7%, = 0.015), midwall fractional shortening < 14% (22.6% vs. 8.8%, = 0.001), and ratio of peak early transmitral filling wave velocity to early diastolic velocity of lateral mitral annulus > 12 (32.7% vs. 16.2%, < 0.001) than those without DM. Multivariate analysis showed that male sex, a history of smoking, high systolic blood pressure, high body mass index, high levels of fasting glucose and total cholesterol, low levels of albumin and hemoglobin, and a low estimated glomerular filtration rate were associated with abnormal echocardiographic findings. The rates of inappropriate left ventricular mass, systolic and diastolic dysfunction were higher in our patients with CKD and DM than in those without DM.

Citing Articles

Epidemiology of heart failure in diabetes: a disease in disguise.

Hoek A, Canto E, Wenker E, Bindraban N, Handoko M, Elders P Diabetologia. 2024; 67(4):574-601.

PMID: 38334818 PMC: 10904471. DOI: 10.1007/s00125-023-06068-2.

Vector flow mapping analysis of left ventricular vortex performance in type 2 diabetic patients with early chronic kidney disease.

Chen X, Qiu F, Wang W, Qi Z, Lyu D, Xue K BMC Cardiovasc Disord. 2023; 23(1):434.

PMID: 37658336 PMC: 10474629. DOI: 10.1186/s12872-023-03474-7.

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention.

Mohan M, Dihoum A, Mordi I, Choy A, Rena G, Lang C Front Cardiovasc Med. 2021; 8:746382.

PMID: 34660744 PMC: 8513785. DOI: 10.3389/fcvm.2021.746382.

Glomerular Filtration Dysfunction is Associated with Cardiac Adverse Remodeling in Menopausal Diabetic Chinese Women.

Song X, Li G, Zhu Y, Laukkanen J Clin Interv Aging. 2021; 16:603-609.

PMID: 33883887 PMC: 8055368. DOI: 10.2147/CIA.S306342.

References

. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

Hartog J, Voors A, Bakker S, Smit A, Van Veldhuisen D . Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail. 2007; 9(12):1146-55. DOI: 10.1016/j.ejheart.2007.09.009. View

Dodiyi-Manuel S, Akpa M, Odia O . Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria. Vasc Health Risk Manag. 2013; 9:529-33. PMC: 3792947. DOI: 10.2147/VHRM.S44540. View

Borbely A, Papp Z, Edes I, Paulus W . Molecular determinants of heart failure with normal left ventricular ejection fraction. Pharmacol Rep. 2009; 61(1):139-45. DOI: 10.1016/s1734-1140(09)70016-7. View

. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-266. View

Oktay A, Lavie C, Milani R, Ventura H, Gilliland Y, Shah S . Current Perspectives on Left Ventricular Geometry in Systemic Hypertension. Prog Cardiovasc Dis. 2016; 59(3):235-246. DOI: 10.1016/j.pcad.2016.09.001. View

Khouri S, Maly G, Suh D, Walsh T . A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiogr. 2004; 17(3):290-7. DOI: 10.1016/j.echo.2003.08.012. View

Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70. DOI: 10.7326/0003-4819-130-6-199903160-00002. View

De Simone G, Devereux R, Kimball T, Mureddu G, Roman M, Contaldo F . Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension. 1998; 31(5):1077-82. DOI: 10.1161/01.hyp.31.5.1077. View

10.

Somaratne J, Whalley G, Poppe K, ter Bals M, Wadams G, Pearl A . Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community. Cardiovasc Diabetol. 2011; 10:29. PMC: 3094210. DOI: 10.1186/1475-2840-10-29. View

11.

Faden G, Faganello G, De Feo S, Berlinghieri N, Tarantini L, Lenarda A . The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study. Diabetes Res Clin Pract. 2013; 101(3):309-16. DOI: 10.1016/j.diabres.2013.07.004. View

12.

Kizer J, Bella J, Palmieri V, Liu J, Best L, Lee E . Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the Strong Heart Study (SHS). Am Heart J. 2006; 151(2):412-8. DOI: 10.1016/j.ahj.2005.04.031. View

13.

Devereux R, Alonso D, Lutas E, Gottlieb G, Campo E, Sachs I . Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57(6):450-8. DOI: 10.1016/0002-9149(86)90771-x. View

14.

Stewart G, Gansevoort R, Mark P, Rooney E, McDonagh T, Dargie H . Electrocardiographic abnormalities and uremic cardiomyopathy. Kidney Int. 2004; 67(1):217-26. DOI: 10.1111/j.1523-1755.2005.00072.x. View

15.

Nardi E, Palermo A, Mule G, Cusimano P, Cottone S, Cerasola G . Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease. J Hypertens. 2009; 27(3):633-41. DOI: 10.1097/HJH.0b013e3283220ecd. View

16.

Somaratne J, Whalley G, Bagg W, Doughty R . Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus. Expert Rev Cardiovasc Ther. 2007; 6(1):109-25. DOI: 10.1586/14779072.6.1.109. View

17.

Chareonthaitawee P, Sorajja P, Rajagopalan N, Miller T, Hodge D, Frye R . Prevalence and prognosis of left ventricular systolic dysfunction in asymptomatic diabetic patients without known coronary artery disease referred for stress single-photon emission computed tomography and assessment of left ventricular function. Am Heart J. 2007; 154(3):567-74. DOI: 10.1016/j.ahj.2007.04.042. View

18.

Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G . Left ventricular hypertrophy in nondiabetic predialysis CKD. Am J Kidney Dis. 2005; 46(2):320-7. DOI: 10.1053/j.ajkd.2005.04.031. View

19.

Lavie C, Patel D, Milani R, Ventura H, Shah S, Gilliland Y . Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog Cardiovasc Dis. 2014; 57(1):3-9. DOI: 10.1016/j.pcad.2014.05.003. View

20.

Daffu G, Hurtado Del Pozo C, OShea K, Ananthakrishnan R, Ramasamy R, Schmidt A . Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond. Int J Mol Sci. 2013; 14(10):19891-910. PMC: 3821592. DOI: 10.3390/ijms141019891. View